Intensity Therapeutics, Inc.
INTS
$1.85
-$0.01-0.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.28% | -50.84% | -34.32% | -244.54% | -110.01% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 104.20% | 45.89% | -77.15% | 181.80% | -36.27% |
| Change in Net Operating Assets | -120.20% | 69.01% | -77.24% | -9,340.00% | 325.47% |
| Cash from Operations | -182.03% | 22.41% | -1,663.18% | -384.57% | 42.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 135.05% | -- | -- | -- |
| Cash from Investing | -100.00% | 135.05% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.58% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -97.80% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 95.80% | -- | -- | -- |
| Cash from Financing | 19,146.15% | -97.99% | 101.24% | -96.10% | -100.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.31% | -107.00% | -778.54% | -57.76% | 202.42% |